Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tasso

Explore full profile

Medical innovation company changing the way diagnostics are delivered

Seattle, United StatesFounded 2012Health Tech & Medtech
Valuation $250–500M Last recorded · 2021
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Tasso and the history behind them.

About Tasso

Tasso Inc. is a healthcare technology company that specializes in patient-centric devices for remote blood sample collection. The company operates in the clinical trial market, providing a convenient and virtually painless solution for blood collection that can be done anytime, anywhere. This is particularly beneficial for decentralized clinical trials, where patients are not required to visit a specific location for their tests.

Tasso's business model revolves around its innovative blood collection devices. These devices are digitally-enhanced, making them easy to use and less painful than traditional methods of blood collection. They are designed to improve patient experience, which can help drive patient recruitment and retention in clinical trials.

The company also offers solutions for population pharmacokinetics (PopPK), a method used in clinical trials to study how a drug is processed in the body. By enhancing data density and fidelity, Tasso's solutions can improve the accuracy and reliability of these studies.

In addition to selling devices, Tasso also provides an integrated logistics platform. This supports shipping, participant engagement, and other aspects of running a decentralized clinical trial. This means that Tasso not only makes money from selling its devices, but also from providing services that help clinical trials run smoothly.

In summary, Tasso Inc. is a healthcare technology company that provides easy-to-use, painless blood collection devices and services for decentralized clinical trials. Its innovative solutions are designed to improve patient experience and enhance the accuracy and reliability of clinical trials.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2012
Headquarters
Seattle, United States
Employees
101
Open positions
1
Dealroom signal
73.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Testing, Clinical, Non-Invasive medical devices and treatments, Health Diagnostics, Wearable, Tech for Patients, Hard Tech
Technology
Hardware, Deep Tech, Connected Device
Business model
Manufacturing
Client focus
b2b

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Dec 2021 $100M $400M D.E. Shaw Group · Foresite Capital · Senvest Capital · J2 Ventures ↗
SERIES AOther financing Jul 2020 $17M $68M Foresite Capital · Merck Global Health Innovation Fund · Techstars · Vertical Venture Partners —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Tasso website traffic

Latest recorded traffic for Tasso is 21K monthly website visits, up 31.3% over the last three months. Tasso's team grew 3.1% over the past year.

Latest monthly visits21K 3-month web change+31.3% 1-year team growth+3.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • MedTech Innovator

Series A13 investors entered at this stage

  • Vertical Venture Partners
  • Techstars
  • Foresite Capital
  • Merck Global Health Innovation Fund
  • Cedars-Sinai
  • RA Capital Management
  • D.E. Shaw Group
  • Senvest Capital
  • J2 Ventures
  • Incube
  • Hambrecht Ducera Growth Ventures
  • SVB Innovation Fund
  • Merck GHIF
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.4%
🇲🇽 Mexico1.6%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tasso on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tasso’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.